2F9V | Viral Protein | date | Dec 06, 2005 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Hcv Ns3 Protease Domain With Ns4a Peptide And A Ketoamide In With P1 And P2 Cyclopropylalannines | ||||||||||||||
authors | S.L.Bogen, S.Ruan, R.Liu, S.Agrawal, J.Pichardo, A.Prongay, B.Baro A.Saksena, V.Girijavallabhan, F.G.Njoroge | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Ns3 Proteasehelicase Chain: A, C Fragment: Protease Domain (Residues : 1-181) Engineered: Yes |
Organism_scientific: Hepatitis C Virus Organism_taxid: 11103 Strain: H Gene: Ns3 Protease Domain ( Residues 1027-1207 Of The Polyp Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Jm109(De3) Expression_system_vector_type: Plasmid Expression_system_plasmid: Ns3(181)His6pet22b | ||||||||||||||
Molecule: Polyprotein Chain: B, D Fragment: Residues 21-39 Engineered: Yes |
Synthetic: Yes Other_details: Solid-Phase Peptide Synthesis Of The Ns4a Re 21-39 Peptide With N-Terminal Kk And C-Terminal Kk Extensio | ||||||||||||||
symmetry | Space Group: H 3 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.60 Å | ||||||||||||
ligand | BN6, ZN | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Depeptidization efforts on P3-P2' alpha-ketoamide inhibitors of HCV NS3-4A serine protease: effect on HCV replicon activity., Bogen SL, Ruan S, Liu R, Agrawal S, Pichardo J, Prongay A, Baroudy B, Saksena AK, Girijavallabhan V, Njoroge FG, Bioorg Med Chem Lett. 2006 Mar 15;16(6):1621-7. Epub 2006 Jan 4. PMID:16387495 |
Data retrieval |
View 2F9V in 3D |
Visual 3D analysis of 2F9V |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2F9V |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |